DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES

Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding., Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3

Chen, 1997, Absorption, distribution, elimination of tea polyphenols in rats., Drug Metab Dispos, 25, 1045

Chow, 2001, Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E., Cancer Epidemiol Biomarkers Prev, 10, 53

Hong, 2003, Involvement of multidrug resistance-associated proteins in regulating cellular levels of (–)-epigallocatechin-3-gallate and its methyl metabolites., Biochem Biophys Res Commun, 310, 222, 10.1016/j.bbrc.2003.09.007

Hong, 2002, Stability, cellular uptake, biotransformation and efflux of tea polyphenol (–)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells., Cancer Res, 62, 7241

Lambert, 2003, Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice., J Nutr, 133, 4172, 10.1093/jn/133.12.4172

Lambert, 2003, Mechanisms of cancer prevention by tea constituents., J Nutr, 133, 3262S, 10.1093/jn/133.10.3262S

Liang, 1997, Suppression of extracellular signals and cell proliferation through EGF receptor binding by (–)-epigallocatechin gallate in human A431 epidermoid carcinoma cells., J Cell Biochem, 67, 55, 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V

Lu, 2003, Glucuronides of tea catechins: enzymology of biosynthesis and biological activities., Drug Metab Dispos, 31, 452, 10.1124/dmd.31.4.452

Lu, 2003, Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (–)-epigallocatechin gallate., Drug Metab Dispos, 31, 572, 10.1124/dmd.31.5.572

Masuda, 2001, Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression and chemosensitivity in human head and neck squamous cell carcinoma cell lines., Clin Cancer Res, 7, 4220

Nam, 2001, Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo., J Biol Chem, 276, 13322, 10.1074/jbc.M004209200

Schneider, 2004, Allometric principles for interspecies extrapolation in toxicological risk assessment—empirical investigations., Regul Toxicol Pharmacol, 39, 334, 10.1016/j.yrtph.2004.03.001

Vaidyanathan, 2003, Cellular uptake and efflux of the tea flavonoid (–)epicatechin-3-gallate in the human intestinal cell line Caco-2., J Pharmacol Exp Ther, 307, 745, 10.1124/jpet.103.054296

Yang, 2002, Inhibition of carcinogenesis by tea., Annu Rev Pharmacol Toxicol, 42, 25, 10.1146/annurev.pharmtox.42.082101.154309

Yang, 2001, The green tea polyphenol (–)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6., Mol Pharmacol, 60, 528, 10.1016/S0026-895X(24)12615-6